HYPERACTIVITY
Foreword
Americans continue
to demand a greater role in deciding issues that affect their
health. Increased health awareness and the convincing evidence
linking lifestyle, risk factors, and specific diseases have
accelerated our need to know.
The Clinical Center,
recognizing the importance of providing information to facilitate
intelligent decisions on health issues, created a unique lecture
series featuring physician scientists working at the frontiers
of biomedical research at the National Institutes of Health.
The Medicine for
the Public series has provided an opportunity for millions of
people to learn more about how their bodies work and what they
can do to maintain to improve their health.
This publication
is one of several adapted from the series. It is our sincere
hope that you will find this material interesting and enlightening.
Saul Rosen, Ph.D.,M.D.
Acting Director
Clinical Center
National Institutes of Health
Alan J. Zametkin,
M.D.
Senior Staff Psychiatrist
Section on Clinical Brain Imaging
Laboratory of Cerebral Metabolism
National Institute of Mental Health
A native of Providence,
Rhode Island, Dr. Alan Zametkin received a bachelor of arts
degree in psychology from Amherst College and a medical degree
from Brown University. He fulfilled a one-year internship in
pediatrics at Stanford University Medical Center, then completed
an adult and child psychiatry training program at the University
of California at Los Angeles.
Dr. Zametkin joined
the Clinical Center in 1980 as a staff psychiatrist in the National
Institute of Mental Health's (NIMH) Child Psychiatry Branch.
Seven years later he became a senior staff psychiatrist in the
Clinical Brain Imaging Section of the NIMH Laboratory of Cerebral
Metabolism.
He and his colleagues
were the first to show clear-cut cerebral metabolic abnormalities
in attention deficit hyperactivity disorder, as well as document
that different stimulants have remarkably dissimilar metabolic
effects in hyperactive children.
|
.gif)
